NCT00494988View on ClinicalTrials.gov

Self-control Trial to Evaluate the Remission Rate in Newly Diagnosed Type 2 Diabetes Patients After Treatment With Insulin Aspart

PHASE4CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

December 31, 2004

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

insulin aspart

DRUG

insulin NPH

Trial Locations (1)

100029

Beijing

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY